A breakthrough compression sock that targets a multi-billion dollar global market for effective wound care management will be showcased to decision makers in the medical technology industry.

Kiwi start-up Footfalls & Heartbeats Limited (FHL) has developed a revolutionary process for manufacturing intelligent textiles where functionality is integrated into the fabric structure to make the textile itself the sensor. FHL has used its textile to create a ‘smart sock’ to support treatment of venous leg ulcers that will help reduce the downstream complications and costs often associated with the condition.

The smart sock, when combined with a multilayer bandage system can measure and convey information to medical staff, allowing health practitioners to ensure optimal pressure, which medical literature suggests will improve treatment outcomes. The compression level can be transferred through a detachable interface which is about the size of a matchbox, opening the way for easy remote monitoring of people with venous leg ulcers.

FHL is working with researchers at North Carolina State University (NCSU), selected as a research partner because NCSU hosts one of the world’s leading smart textile groups as well as the Centre for Robotics & Intelligent Machines which has specialist expertise in the interface between textiles and information output.

FHL’s founder and Chief Operating Officer Simon McMaster says the company’s skin friendly sock is truly disruptive technology for the wound healing market and he expects keen interest in the product at Advamed.

“It’s an opportunity for us to meet people working at the front line of wound healing and for movers and shakers in the medical technology field to see first-hand what our product can do.

“Our technology has a wide range of other potential applications in the medical technology area, including compression therapy for burns rehabilitation and lymphedema. AdvaMed is a perfect forum to progress some of these future opportunities.”

There is strong interest in FHL’s technology, with the company expecting to begin commercialising its compression sock through a partner in the United States early in 2014.

FHL is also offering a range of licensing opportunities, which it will be discussing with potential partners at AdvaMed.

FHL’s Managing Director Brent Ogilvie says AdvaMed is a forum for the company to make new connections and highlight its technology in the world’s largest market for wound healing and other healthcare products.

“FHL has already attracted funding and resources from a number of quality investors and developed promising business relationships with potential licensees. AdvaMed will build on that and I am confident it will help the company move to the next level,” he says.